Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-046402

Director bought 250,000 shares at an average $1.30 ($325,737)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamond David Director 2023-08-15 Purchase +107,886 $1.32 $142,410 1,954,995 I
Lamond David Director 2023-08-16 Purchase +117,348 $1.29 $151,379 2,072,343 I
Lamond David Director 2023-08-17 Purchase +24,766 $1.29 $31,948 2,097,109 I
Open-market purchases · 250,000 sh · avg $1.30 · $325,737
Loading xslF345X05/doc4.xml…